跳至主要内容
临床试验/ISRCTN39143623
ISRCTN39143623已完成不适用

Pentoxifylline and vitamin E treatment for prevention of radiation induced side effects in women with breast cancer

und University Hospital (Sweden)0 个研究点目标入组 80 人开始时间: 2007年10月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Women (no age limit) with breast cancer
  • 2. Treated with axillary dissection, mastectomy or segmental resection of the breast, and radiotherapy to the breast and axilla
  • 3. All active cancer treatment is terminated, except for anti-hormone treatment with tamoxifen, letrozol, anastrozole, and exemestane
  • 4. Able to understand the nature of the trial and give written informed consent

排除标准

  • 1. Known sensitivity to pentoxifylline or vitamin E
  • 2. Disorders related to muscles or joints
  • 3. Corticosteroid treatment during radiotherapy treatment

研究者

发起方
und University Hospital (Sweden)

相似试验

Pentoxifylline and vitamin E treatment for... | 临床试验